Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Tablets 30 X 5 mg |
|
27971 | 5173 |
|
Tablets 30 X 10 mg |
|
27972 | 5174 |
|
Tablets 30 X 20 mg |
|
27973 | 5172 |
Related information
Dosage
This medicine should be used at set intervals as determined by the attending doctor.
The medicine should be taken with water. The medicine may be taken with
or without food.
Do not chew; the tablet is intended to be swallowed! The tablet can be
halved.
See prescribing information for full details.
Indications
Essential hypertension, renovascular hypertension, congestive heart failure and to reduce mortality in patients with all degress of heart failure. To retard the development of symptomatic heart failure in asympyomatic patients with left ventricular dysfunction.
Contra-Indications
Known hypersensitivity, history of angioedema related to previous treatment with an ACE inhibitor, pregnancy.
Special Precautions
Angioedema of the face, extremities, lips, tongue, glottis and/or larynx has been reported. Excessive hypotension, patients with ischemic heart or cerebrovascular disease. Periodic monitoring of white blood cell counts in patients with collagen vascular disease and renal disease should be considered. Lactation, pediatrics, impaired renal function, hyperkalemia, surgery/anesthesia, cough.
See prescribing information for full details.
Side Effects
Adverse experiences were mild and transient in nature. In clinical trials, discontinuation of therapy due to clinical adverse experiences was required in 3.3% of patients with hypertension, and in 5.7% of patients with heart failure. Fatigue, orthostatic effects, asthenia, diarrhea, nausea, headache, dizziness, cough, rash.
See prescribing information for full details.
Drug interactions
Alcohol, allopurinol, NSAIDs, antidepressants, antidiabetics, cyclosporin, diuretics, lithium, nitrates, estrogens and progesterones, potassium salts, carbenoxolone.
